It seems we can’t find what you’re looking for. Perhaps searching can help.
1843 - 1973
London Health Sciences Centre – phase I/II of durvalumab (medi4736) + tremelimumab + stereotactic body radiotherapy for metastatic head and neck carcinoma
London Health Sciences Centre – phase I/II of durvalumab (medi4736) + tremelimumab + stereotactic body radiotherapy for metastatic head and neck carcinoma
It seems we can’t find what you’re looking for. Perhaps searching can help.